Adalimumab Earns FDA Approval for Ulcerative Colitis in Children ...Middle East

News by : (Medscape) -
Adalimumab has received approval from the Food and Drug Administration for use in pediatric patients aged 5 years and older with moderately to severely active ulcerative colitis. FDA Approvals

Hence then, the article about adalimumab earns fda approval for ulcerative colitis in children was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Adalimumab Earns FDA Approval for Ulcerative Colitis in Children )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار